Status:
RECRUITING
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
Lead Sponsor:
Vanderbilt-Ingram Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Lung Cancer
Eligibility:
All Genders
18-120 years
Brief Summary
RATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that may occur in RNA and identify biomarkers related to cancer. PURP...
Detailed Description
OBJECTIVES: * Develop statistical and computational methods for modeling the relationships between multiple variable protein and RNA expression data and clinical endpoints using both supervised and u...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Diagnosis of non-small cell lung cancer
- Clinical stage I and II disease
- Resectable disease and complete surgical resection planned
- Treated on companion studies at Vanderbilt University, the Veterans Administration hospital, St. Thomas, and Vanderbilt-Ingram Cancer Center Affiliate Network
- Tumor specimen samples must be available at resection
- Exclusion criteria
- Chemotherapy before surgery
- Radiotherapy before surgery
Exclusion
Key Trial Info
Start Date :
May 1 2001
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2031
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT00897117
Start Date
May 1 2001
End Date
May 31 2031
Last Update
September 26 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Dan Rudy Cancer Center at Saint Thomas Hospital
Nashville, Tennessee, United States, 37205
2
Veterans Affairs Medical Center - Nashville
Nashville, Tennessee, United States, 37212
3
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States, 37232-6838